Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Breast Neoplasms 5Recurrence 4Lung Neoplasms 4Hodgkin Disease 4Carcinoma, Non-Small-Cell Lung 4Uterine Cervical Neoplasms 2Rhabdomyosarcoma 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma 2Adenocarcinoma of Lung 2Sarcoma 1Rhabdomyosarcoma, Embryonal 1Rhabdomyosarcoma, Alveolar 1Prostatic Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasm Metastasis 1Melanoma 1Familial ependymoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Vincristine 6Radiotherapy 5Prednisone 5Doxorubicin 5Cyclophosphamide 5Gemcitabine 4Cisplatin 4Rituximab 3Methotrexate 3Cytarabine 3Crizotinib 3ibritumomab tiuxetan 2Vinorelbine 2Methylprednisolone 2Etoposide 2Drug Therapy 2Dexamethasone 2merphos 1liposomal amphotericin B 1ixabepilone 1imetelstat 1Whole-Body Irradiation 1Watchful Waiting 1Vinblastine 1VAP-cyclo protocol 1Topotecan 1Stem Cell Transplantation 1Standard of Care 1Specimen Handling 1Razoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Large-Cell, Anaplastic × Vinorelbine × Clear all
NCT03443128 2025-02-13

Vinorelbine for Recurrent ALCL-2017

Children's Cancer Group, China

Phase 2 Completed
20 enrolled
Lymphoid

Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT03397953 2022-07-26

Vinorelbine for Recurrent ACLC

Children's Cancer Group, China

Phase 2 Completed
20 enrolled
Lymphoid

Recurrence, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡